ALKS (Alkermes) FFO


ALKS Alkermes PLC ALKS
70 GF Score
Price $50.45
GF Value $31.33
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Alkermes FFO?

FFO (Funds from operations) only applies to REITs.

ALKS
70GF Score
Alkermes PLC ALKS
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Alkermes (ALKS) Overvalued in 2026?

Based on GuruFocus' analysis, Alkermes stock appears to be overvalued. The current stock price of $50.45 is trading 61% above its estimated GF Value™ of $31.33. GuruFocus considers Alkermes to be Significantly Overvalued.

Key valuation signals for ALKS:

  • FFO:
  • GF Value™: $31.33 vs. price of $50.45 (61% above fair value)
  • GF Score™: 70/100 with 8 warning signs

No single metric tells the full story. See the ALKS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alkermes Business Description

Other Exchanges 8AK:Germany
Address 1 Burlington Road, Connaught House, Dublin, IRL, D04 C5Y6
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
70GF Score

Get the complete analysis for ALKS

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$50.45
Price
$31.33
GF Value